Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico. The company is headquartered in Franklin, Tennessee. As of 2024, Acadia operated over 50 inpatient psychiatric hospitals in 19 U.S. states, including Arizona, Arkansas, Florida, Georgia, Indiana, Michigan, Missouri, New Mexico, Ohio, Oklahoma, Pennsylvania, Tennessee, Utah, and Wisconsin. It is one of the country's largest hospital systems. It also operates, as of 2024, 165 methadone clinics in 33 states, making it the U.S.'s largest methadone-clinic chain.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| ACHC | Acadia Healthcare Company, Inc. | 2026-03-03 03:59:29 | 23.38 | -0.06 | -0.26 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACHC | 0001520697 | Acadia Healthcare Company, Inc. | US00404A1097 | 5493005CW985Y9D0NC11 | — | Nasdaq | 8093 | Services-Specialty Outpatient Facilities, NEC | 1231 | DE | 6100 TOWER CIRCLE | FRANKLIN | TN | 37067 | UNITED STATES | US | 615-861-6000 | 6100 TOWER CIRCLE, FRANKLIN, TN, 37067 | 6100 TOWER CIRCLE, FRANKLIN, TN, 37067 | — | — | 2005 | — | 28,600 | http://acadiahealthcare.com | 6,100,000,000 | 90,431,462 | 92,258,166 | Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico. The company is headquartered in Franklin, Tennessee. As of 2024, Acadia operated over 50 inpatient psychiatric hospitals in 19 U.S. states, including Arizona, Arkansas, Florida, Georgia, Indiana, Michigan, Missouri, New Mexico, Ohio, Oklahoma, Pennsylvania, Tennessee, Utah, and Wisconsin. It is one of the country's largest hospital systems. It also operates, as of 2024, 165 methadone clinics in 33 states, making it the U.S.'s largest methadone-clinic chain. | 2026-02-26 17:41:22 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 2,100,000,000 | -4,000,000,000 | -65.5738 | 92,211,777 | -701,265 | -0.7548 |
| 2024 | 6,100,000,000 | -1,000,000,000 | -14.0845 | 92,913,042 | 623,974 | 0.6761 |
| 2023 | 7,100,000,000 | 1,100,000,000 | 18.3333 | 92,289,068 | 974,452 | 1.0671 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Brian P. Farley | Secretary, Executive Vice President, General Counsel | 2024 | 566,500 | 400,000 | 1,419,893 | 364,268 | 58,991 | 2,809,652 |
| Nasser Khan | Chief Operating Officer | 2024 | 448,035 | 98,437 | 1,198,831 | 168,003 | 8,250 | 1,921,556 |
| Christopher H. Hunter | Chief Executive Officer | 2024 | 1,020,000 | 0 | 5,099,925 | 967,319 | 1,923 | 7,089,167 |
| Heather Dixon | Chief Financial Officer | 2024 | 710,700 | 300,000 | 2,099,865 | 457,500 | 0 | 3,568,065 |
| John S. Hollinsworth | Executive Vice President | 2024 | 386,015 | 0 | 0 | 209,028 | 59,597 | 654,640 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 25,000 |
| 2024 | 25,500 |
| 2023 | 23,500 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 3,312,769,000 | 3,153,963,000 | 2,928,738,000 |
| Cost Of Revenue | — | — | — |
| Gross Profit | — | — | — |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 177,600,000 | 156,800,000 | 153,300,000 |
| Operating Expenses | 4,378,710,000 | 2,812,084,000 | 2,954,098,000 |
| Operating Income | — | — | — |
| Net Income | -1,102,772,000 | 255,612,000 | -21,667,000 |
| Earnings Per Share Basic | -12.16 | 2.79 | -0.24 |
| Earnings Per Share Diluted | -12.16 | 2.78 | -0.24 |
| Weighted Average Shares Outstanding Basic | 90,705,000 | 91,621,000 | 90,949,000 |
| Weighted Average Shares Outstanding Diluted | 90,705,000 | 92,059,000 | 90,949,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 133,242,000 | 76,305,000 | 100,073,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 440,604,000 | 365,339,000 | 361,451,000 |
| Inventories | 5,686,000 | 5,654,000 | 5,300,000 |
| Non Trade Receivables | 41,900,000 | 31,900,000 | 12,400,000 |
| Other Assets Current | 240,293,000 | 135,848,000 | 134,476,000 |
| Total Assets Current | 814,139,000 | 577,492,000 | 596,000,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 3,111,212,000 | 2,853,193,000 | 2,266,610,000 |
| Other Assets Non Current | 72,550,000 | 52,043,000 | 72,553,000 |
| Total Assets Non Current | 4,713,309,000 | 5,379,423,000 | 4,762,841,000 |
| Total Assets | 5,527,448,000 | 5,956,915,000 | 5,358,841,000 |
| Accounts Payable | 150,403,000 | 232,704,000 | 156,132,000 |
| Deferred Revenue | 2,805,000 | 1,686,000 | 2,165,000 |
| Short Term Debt | 28,438,000 | 76,816,000 | 29,219,000 |
| Other Liabilities Current | 17,285,000 | 5,964,000 | 7,783,000 |
| Total Liabilities Current | 525,194,000 | 577,919,000 | 885,781,000 |
| Long Term Debt | 2,499,967,000 | 1,956,909,000 | 1,371,767,000 |
| Other Liabilities Non Current | 201,607,000 | 122,298,000 | 140,113,000 |
| Total Liabilities Non Current | 2,861,702,000 | 2,188,165,000 | 1,585,400,000 |
| Total Liabilities | 3,386,896,000 | 2,766,084,000 | 2,471,181,000 |
| Common Stock | 905,000 | 918,000 | 913,000 |
| Retained Earnings | -765,841,000 | 387,333,000 | 131,721,000 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | 1,948,960,000 | 3,073,715,000 | 2,781,974,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 189,249,000 | 149,595,000 | 132,349,000 |
| Share Based Compensation Expense | 31,708,000 | 37,113,000 | 32,289,000 |
| Other Non Cash Income Expense | -1,623,000 | 4,686,000 | -3,168,000 |
| Change In Accounts Receivable | 75,024,000 | 2,329,000 | 39,012,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 14,882,000 | -420,893,000 | 17,404,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 131,898,000 | 129,693,000 | 462,340,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 571,807,000 | 690,385,000 | 424,133,000 |
| Acquisition Of Business | 8,165,000 | 53,550,000 | 349,000 |
| Other Investing Activities | 90,000 | 2,979,000 | 2,159,000 |
| Cash From Investing Activities | -556,214,000 | -736,479,000 | -397,219,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 50,034,000 | — | — |
| Issuance Of Long Term Debt | 1,200,000,000 | 350,000,000 | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | -90,000 | — | 37,000 |
| Cash From Financing Activities | 481,253,000 | 583,018,000 | -62,697,000 |
| Change In Cash | 56,937,000 | -23,768,000 | 2,424,000 |
| Cash At End Of Period | 133,242,000 | 76,305,000 | 100,073,000 |
| Income Taxes Paid | 30,094,000 | 28,148,000 | 66,397,000 |
| Interest Paid | 124,663,000 | 113,401,000 | 80,745,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -12.16 | 2.79 | -0.24 |
| Price To Earnings Ratio | -1.1669 | 14.2115 | -324 |
| Earnings Growth Rate | -535.8423 | -1,262.5 | -107.8689 |
| Price Earnings To Growth Ratio | 0.0022 | -0.0113 | 3.0036 |
| Book Value Per Share | 23.5991 | 34.8264 | 31.7503 |
| Price To Book Ratio | 0.6013 | 1.1385 | 2.4491 |
| Ebitda | -1,022,293,000 | 316,987,000 | 94,954,000 |
| Enterprise Value | 3,682,266,950 | 5,590,192,650 | 8,373,107,240 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 1.2973 | 0.6617 | 0.5036 |
| Capital Expenditures | 447,268,000 | 736,178,000 | 446,914,000 |
| Free Cash Flow | -315,370,000 | -606,485,000 | 15,426,000 |
| Return On Equity | -0.5658 | 0.0832 | -0.0078 |
| One Year Beta | 0.7784 | 0.5951 | 0.8566 |
| Three Year Beta | 0.7529 | 0.8162 | 0.9295 |
| Five Year Beta | 0.8494 | 1.1741 | 1.2188 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Farley Brian | EVP, GC and Secretary | 2026-02-27 | 1,915 | D | 69,165 |
| OSTEEN DEBRA K | Director, Chief Executive Officer | 2026-01-20 | 1,125,000 | A | 1,125,000 |
| YOUNG TODD S. | Chief Financial Officer | 2025-10-27 | 48,445 | A | 48,445 |
| Khan Nasser | Chief Operating Officer | 2025-09-30 | 973 | D | 55,023 |
| Farley Brian | EVP, GC and Secretary | 2025-07-26 | 1,095 | D | 71,080 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Susie Lee | 2022-12-29 | NV03 | Sale | 2022-11-30 | Joint | $1,001 - $15,000 |
| Peter Meijer | 2021-03-16 | MI03 | Sale | 2021-02-16 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 2025-12-31 | 75,562 | 5,325 | 14.19 |
| Aristides Capital LLC | 2025-12-31 | 195,822 | 13,800 | 14.19 |
| FMR LLC | 2025-12-31 | 76,882,663 | 5,418,088 | 14.19 |
| Parkman Healthcare Partners LLC | 2025-12-31 | 1,419,000 | 100,000 | 14.19 |
| AMERIPRISE FINANCIAL INC | 2025-12-31 | 10,922,355 | 769,722 | 14.19 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| PIMCO Equity Series | 2025-12-31 | Class A | PMJAX | 250,209 | 3,550,465.71 | 0.1181 |
| PIMCO Equity Series | 2025-12-31 | I-2 | PMJPX | 250,209 | 3,550,465.71 | 0.1181 |
| PIMCO Equity Series | 2025-12-31 | Institutional Class | PMJIX | 250,209 | 3,550,465.71 | 0.1181 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class C | RYYCX | 37,741 | 535,544.79 | 1.0955 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class A | RYSVX | 37,741 | 535,544.79 | 1.0955 |